Home Point Capital upgraded by Wedbush with a new price target
$HMPT
Finance: Consumer Services
Finance
Wedbush upgraded Home Point Capital from Neutral to Outperform and set a new price target of $1.50 from $4.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/11/2022 | $4.00 → $1.50 | Neutral → Outperform | Wedbush |
| 8/15/2022 | $5.50 → $4.00 | Outperform → Neutral | Wedbush |
| 4/13/2022 | Mkt Outperform → Mkt Perform | JMP Securities | |
| 2/25/2022 | $8.00 → $6.50 | Outperform | Credit Suisse |
| 2/25/2022 | $4.00 → $3.75 | Equal-Weight | Morgan Stanley |
| 2/25/2022 | $4.00 | Overweight → Equal-Weight | Wells Fargo |
| 2/22/2022 | $5.00 → $4.00 | Underperform | B of A Securities |
| 1/19/2022 | Overweight → Underweight | JP Morgan |
Wedbush upgraded Home Point Capital from Neutral to Outperform and set a new price target of $1.50 from $4.00 previously
Wedbush downgraded Home Point Capital from Outperform to Neutral and set a new price target of $4.00 from $5.50 previously
JMP Securities downgraded Home Point Capital from Mkt Outperform to Mkt Perform
ANN ARBOR, Mich., May 12, 2023 (GLOBE NEWSWIRE) -- Home Point Capital Inc. (NASDAQ:HMPT) (together with its subsidiaries, "Home Point Capital" or the "Company"), the parent entity of Home Point Financial Corporation ("Homepoint"), today announced its financial results for the first quarter ended March 31, 2023. In addition, as previously disclosed during the second quarter of 2023, the Company has announced the following two strategic transactions: On May 10, 2023, the Company announced the signing of a definitive agreement (the "Merger Agreement") that provides for a wholly owned subsidiary of Mr. Cooper Group Inc. ("Mr. Cooper") to commence a tender offer (the "Offer") to acquire all o
– Quarterly Origination Volume of $1.7 billion – – $89.1 million reduction in total expenses compared to fourth quarter of prior year – – Available liquidity of $662.5 million – – Fourth Quarter 2022 Net Loss of $36.8 million, or $(0.27) per Share – ANN ARBOR, Mich., March 09, 2023 (GLOBE NEWSWIRE) -- Home Point Capital Inc. (NASDAQ:HMPT) (together with its subsidiaries, "Home Point Capital" or the "Company"), the parent entity of Home Point Financial Corporation ("Homepoint"), today announced its financial results for the fourth quarter and full year ended December 31, 2022. "As 2022 was largely characterized by an increasingly challenging market, our primary strategic focus was on r
ANN ARBOR, Mich., March 01, 2023 (GLOBE NEWSWIRE) -- Home Point Capital Inc. (NASDAQ:HMPT) ("Home Point Capital" or the "Company"), the parent entity of Home Point Financial Corporation ("Homepoint"), announced today that it will release its financial results for the fourth quarter and fiscal year ended December 31, 2022 before the market opens on March 9, 2023. The company will host a conference call and live webcast to review the company's financial results on the same day at 8:30 am ET. The conference call may be accessed by dialing (877) 423-9813 (toll-free) or (201) 689-8573 (international), using the passcode 13733909. The number should be dialed at least ten minutes prior to the st
SC 13G/A - Home Point Capital Inc. (0001830197) (Subject)
SC 13G - Home Point Capital Inc. (0001830197) (Subject)
15-12G - Home Point Capital Inc. (0001830197) (Filer)
8-K - Home Point Capital Inc. (0001830197) (Filer)
SC 14D9/A - Home Point Capital Inc. (0001830197) (Subject)
IRVINE, Calif., Feb. 11, 2021 /PRNewswire/ -- Interlink Electronics, Inc. (OTC: LINK), a world-leading trusted advisor and technology partner in the rapidly advancing world of human-machine interface (HMI) devices, sensors, and other cutting-edge technologies, today announced that Maria Fregosi has accepted a seat on the company's board of directors. Fregosi brings substantial financial expertise to the company. Fregosi currently serves as Chief Investment Officer of national mortgage lender Homepoint (NASDAQ: HMPT), which she joined as a founding member in 2015. Since she joined Homepoint, the company has grown to a top-10 non-bank mortgage lender, most recently recording $62 billion in
Mr. Cooper Group Inc. (NASDAQ:COOP) ("Mr. Cooper") announced today that Heisman Merger Sub, Inc. ("Purchaser"), a wholly owned subsidiary of Mr. Cooper, has extended the expiration date of its offer (the "Offer") to acquire all of the outstanding shares of common stock of Home Point Capital Inc. (NASDAQ:HMPT) ("Home Point"), par value $0.0000000072 per share ("Shares"), for $2.33 per Share, net to the seller in cash, without interest thereon and subject to any required withholding, pursuant to the Agreement and Plan of Merger, dated as of May 10, 2023, by and among Mr. Cooper, Home Point, and Purchaser. The Offer, which was previously scheduled to expire at 5:00 p.m., Eastern Time, on Jul
Mr. Cooper Group Inc. (NASDAQ:COOP) ("Mr. Cooper") announced today that Heisman Merger Sub, Inc. ("Purchaser"), a wholly owned subsidiary of Mr. Cooper, has extended the expiration date of its offer (the "Offer") to acquire all of the outstanding shares of common stock of Home Point Capital Inc. (NASDAQ:HMPT) ("Home Point"), par value $0.0000000072 per share ("Shares"), for $2.33 per Share, net to the seller in cash, without interest thereon and subject to any required withholding, pursuant to the Agreement and Plan of Merger, dated as of May 10, 2023, by and among Mr. Cooper, Home Point, and Purchaser. The Offer, which was previously scheduled to expire at 5:00 p.m., Eastern Time, on Jun
ANN ARBOR, Mich., May 12, 2023 (GLOBE NEWSWIRE) -- Home Point Capital Inc. (NASDAQ:HMPT) (together with its subsidiaries, "Home Point Capital" or the "Company"), the parent entity of Home Point Financial Corporation ("Homepoint"), today announced its financial results for the first quarter ended March 31, 2023. In addition, as previously disclosed during the second quarter of 2023, the Company has announced the following two strategic transactions: On May 10, 2023, the Company announced the signing of a definitive agreement (the "Merger Agreement") that provides for a wholly owned subsidiary of Mr. Cooper Group Inc. ("Mr. Cooper") to commence a tender offer (the "Offer") to acquire all o
4 - Home Point Capital Inc. (0001830197) (Issuer)
4 - Home Point Capital Inc. (0001830197) (Issuer)
4 - Home Point Capital Inc. (0001830197) (Issuer)
Mr. Cooper Group Inc. (NASDAQ:COOP) ("Mr. Cooper") announced today that Heisman Merger Sub, Inc. ("Purchaser"), a wholly owned subsidiary of Mr. Cooper, has extended the expiration date of its offer (the "Offer") to acquire all of the outstanding shares of common stock of Home Point Capital Inc. (NASDAQ:HMPT) ("Home Point"), par value $0.0000000072 per share ("Shares"), for $2.33 per Share, net to the seller in cash, without interest thereon and subject to any required withholding, pursuant to the Agreement and Plan of Merger, dated as of May 10, 2023, by and among Mr. Cooper, Home Point, and Purchaser. The Offer, which was previously scheduled to expire at 5:00 p.m., Eastern Time, on July
Mr. Cooper Group Inc. (NASDAQ:COOP) ("Mr. Cooper") announced today that Heisman Merger Sub, Inc. ("Purchaser"), a wholly owned subsidiary of Mr. Cooper, has extended the expiration date of its offer (the "Offer") to acquire all of the outstanding shares of common stock of Home Point Capital Inc. (NASDAQ:HMPT) ("Home Point"), par value $0.0000000072 per share ("Shares"), for $2.33 per Share, net to the seller in cash, without interest thereon and subject to any required withholding, pursuant to the Agreement and Plan of Merger, dated as of May 10, 2023, by and among Mr. Cooper, Home Point, and Purchaser. The Offer, which was previously scheduled to expire at 5:00 p.m., Eastern Time, on June
Upgrades According to SVB Leerink, the prior rating for Bolt Biotherapeutics Inc (NASDAQ:BOLT) was changed from Market Perform to Outperform. In the first quarter, Bolt Biotherapeutics showed an EPS of $0.45, compared to $0.64 from the year-ago quarter. At the moment, the stock has a 52-week-high of $2.72 and a 52-week-low of $1.18. Bolt Biotherapeutics closed at $1.60 at the end of the last trading period. According to Tudor Pickering, the prior rating for Montauk Renewables Inc (NASDAQ:MNTK) was changed from Sell to Hold. For the first quarter, Montauk Renewables had an EPS of $0.03, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $20.78 and a 52-week-low of $